Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy
Carly Bess Scalise(Medical University of South Carolina), Ann Richmond(Monroe Carell Jr. Children's Hospital), Caroline A. Nebhan(VA Tennessee Valley Healthcare System), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Anna E. Vilgelm(The Ohio State University), Ingrid A. Mayer(Vanderbilt University), Vandana G. Abramson(Vanderbilt University), Lauren S. Starnes(Vanderbilt University Medical Center), Chi Yan(Vanderbilt University), Jinming Yang(Hershey (United States)), Gregory D. Ayers(Vanderbilt University)
Cited by 6
Related Papers
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|572
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
|npj Breast Cancer|2016|446